Capital Markets and Public M&A

We give qualified advice on company law and legal matters regarding capital markets to listed companies, their owners and other stakeholders acting on the Swedish stock market.

As a leading team in this area, we have in depth knowledge of the regulatory system for stock market transactions, and can add value in both strategic and structural matters.

The team is heavily involved in developing the regulations in this area, and we have well established contacts with authorities and other participants on the Swedish stock market.

Through our international network, we regularly handle transactions that span two or more jurisdictions.

Our consultancy

The team has specialist competence in Equity Capital Market transactions (such as listings, capital raising and sell downs), as well as public M&A.

Vinge also has extensive experience advising on: disclosure matters (rules on disclosure of information, market abuse and disclosure of shareholding and short selling); corporate governance (preparing for general meetings, questions about board composition and reporting); and incentive programmes for listed companies.

Because no two transactions are the same, we put together a unique team for each project – one that is built around the client’s needs.

Our collective expertise

Clients will find they work with a team that has detailed knowledge of business law and is readily available to them.  Because we are a full-service firm, we can support our clients in all their business law matters.

What the ranking organisations say

“Agile, attentive and quick … they focus on the important issues and give practical advice … Clients also praise the team’s responsiveness, noting: ‘They are very quick to respond to all enquiries and have a commercial approach.’” (Chambers and Partners)

 

Related

Vinge advises Veoneer in connection with its USD 600 million capital raise 

Veoneer, Inc. (“Veoneer”) has completed a USD 600 million capital raise, consisting of two concurrent offerings of USD 420 million of shares of common stock and USD 180 million aggregate principal amount of convertible senior notes due 2024.

May 23, 2019

Vinge assists Nuevolution in connection with Amgen’s cash offer 

Vinge has assisted Nuevolution AB (publ) (“Nuevolution”) in connection with the cash offer to the shareholders in Nuevolution by Amgen Inc. (“Amgen”).

May 22, 2019

Vinge advises Oriflame in connection with the offer from the af Jochnick family

The founder family af Jochnick, through Walnut Bidco Plc, has announced a cash offer for Oriflame Holding AG.

May 22, 2019